Published in J Autoimmun on May 01, 2010
H1N1 infection-induced thyroid storm. Ann Thorac Med (2010) 1.54
Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun (2012) 1.43
Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J Biol Chem (2011) 1.12
Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev (2013) 1.05
Hashimoto's Thyroiditis: From Genes to the Disease. Curr Genomics (2011) 1.01
Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol (2012) 0.93
Management of Hepatitis C Antiviral Therapy Adverse Effects. Curr Hepat Rep (2010) 0.92
Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res (2011) 0.91
Diabetes and Hepatitis C: A Two-Way Association. Front Endocrinol (Lausanne) (2015) 0.89
Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy. Mediators Inflamm (2015) 0.82
Analysis of Associations of Human BAFF Gene Polymorphisms with Autoimmune Thyroid Diseases. PLoS One (2016) 0.82
Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis. Arch Med Sci (2011) 0.80
T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1. J Autoimmun (2011) 0.80
Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines. J Interferon Cytokine Res (2015) 0.78
Thyroid autoantibodies are rare in nonhuman great apes and hypothyroidism cannot be attributed to thyroid autoimmunity. Endocrinology (2013) 0.78
Interferon-alpha induced and ribavirin induced thyroid dysfunction in patients with chronic hepatitis C. Hepat Mon (2010) 0.78
Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto Immun Highlights (2013) 0.78
New treatments for chronic hepatitis C: an overview for paediatricians. World J Gastroenterol (2014) 0.77
Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin. Int J Clin Exp Med (2015) 0.76
Celiac disease: a model disease for gene-environment interaction. Cell Mol Immunol (2011) 0.76
Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature. BMC Res Notes (2013) 0.76
HEPATITIS C VIRUS E2 PROTEIN INDUCES UPREGULATION OF IL-8 PATHWAYS AND PRODUCTION OF HEAT SHOCK PROTEINS IN HUMAN THYROID CELLS. J Clin Endocrinol Metab (2016) 0.75
Explosion of autoimmune diseases and the mosaic of old and novel factors. Cell Mol Immunol (2011) 0.75
Thyroid Dysfunction in Non-Interferon Treated Hepatitis C Patients Residing in Hepatitis Endemic Area. Biomed Res Int (2017) 0.75
Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis. Semin Immunopathol (2012) 0.75
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med (2002) 36.55
Molecular mimicry and autoimmune disease. Cell (1987) 5.31
Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science (2002) 3.05
The interferons. Mechanisms of action and clinical applications. JAMA (1991) 2.68
High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology (1993) 2.65
Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist (2001) 2.22
Thyroid disorders in chronic hepatitis C. Am J Med (2004) 2.19
Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells. Proc Natl Acad Sci U S A (1973) 2.11
Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab (2001) 2.10
Infection, thyroid disease, and autoimmunity. Endocr Rev (1993) 2.08
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res (1998) 2.04
Side effects of therapy for chronic hepatitis C. Gastroenterology (2003) 2.04
Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev (2003) 1.85
The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun (2009) 1.81
Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy. J Intern Med (2002) 1.80
Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med (1998) 1.70
Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev (2008) 1.66
Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am (2007) 1.63
New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology (1997) 1.62
The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun (2008) 1.61
Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J Infect Dis (2006) 1.60
The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol (1994) 1.59
Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol (1995) 1.58
Interferons: mechanisms of action and clinical applications. Curr Opin Oncol (2003) 1.56
The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun (2007) 1.55
Interferon-alpha and autoimmune thyroid disease. Thyroid (2003) 1.53
The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (2006) 1.49
HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun (2008) 1.35
Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis (2003) 1.33
Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol (1997) 1.28
Iodine: an environmental trigger of thyroiditis. Autoimmun Rev (2002) 1.28
Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab (2001) 1.26
Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet (1985) 1.26
The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun (2007) 1.25
Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology (1992) 1.22
Thyroid disorders in chronic hepatitis C virus infection. Thyroid (2006) 1.21
Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) (1996) 1.19
Antibodies to Yersinia enterocolitica in thyroid disease. Ann Intern Med (1976) 1.16
Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med (1996) 1.16
Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis. Clin Endocrinol (Oxf) (2002) 1.16
Type I interferons and T helper development. Immunol Today (2000) 1.14
Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem (2003) 1.13
Serological evidence for the role of bacterial infections in the pathogenesis of thyroid diseases. Acta Med Scand (1986) 1.12
Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmun (2000) 1.09
Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity. Autoimmun Rev (2004) 1.04
Autoimmune aspects of cytokine and anticytokine therapies. Am J Med (2003) 1.03
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. Eur J Endocrinol (2002) 1.01
Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis. J Clin Endocrinol Metab (1995) 0.99
Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol (1998) 0.99
Sex steroid regulation of autoimmunity. J Steroid Biochem Mol Biol (1991) 0.99
'Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease. J Clin Endocrinol Metab (2008) 0.97
Autoimmunity. The pathogen connection. Nature (1998) 0.97
The geographical distribution of thyrotoxicosis in England according to the presence or absence of TSH-receptor antibodies. Clin Endocrinol (Oxf) (1985) 0.95
Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection. Clin Endocrinol (Oxf) (2007) 0.95
Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia. J Endocrinol Invest (1999) 0.95
Biologic responses to IFN-alpha administration in humans. J Interferon Cytokine Res (2000) 0.93
Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol (Oxf) (1993) 0.93
Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol (2008) 0.93
The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol (1999) 0.93
Antibodies to plasmid-encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet (1988) 0.92
Hepatitis C and thyroid autoimmunity: is there a link? Am J Med (2004) 0.91
Persistent thyroid autoimmunity after subacute thyroiditis. J Clin Lab Immunol (1987) 0.90
Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Thyroid (2002) 0.90
Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures. J Clin Endocrinol Metab (2004) 0.90
Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol (1995) 0.89
Too early to dismiss Yersinia enterocolitica infection in the aetiology of Graves' disease: evidence from a twin case-control study. Clin Endocrinol (Oxf) (2008) 0.89
Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. Horm Res (1995) 0.88
Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis. Clin Microbiol Infect (2001) 0.87
HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. J Hepatol (1999) 0.87
Modifying effects of iodine on the immunogenicity of thyroglobulin peptides. J Autoimmun (2007) 0.87
Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid (2004) 0.86
Cytotoxic T-lymphocyte antigen-4 gene polymorphisms and human T-cell lymphotrophic virus-1 infection: their associations with Hashimoto's thyroiditis in Japanese patients. Thyroid (2002) 0.86
Failure to find an association between hepatitis C virus and thyroid autoimmunity. Thyroid (1997) 0.85
Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun (2001) 0.85
Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C. Med Sci Monit (2001) 0.85
Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha. Chin Med J (Engl) (1999) 0.83
By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis in the GFP+ fluorescent mouse. Clin Immunol (2006) 0.83
Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease. Neuro Endocrinol Lett (2001) 0.82
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. Thyroid (2009) 0.81
The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease. J Clin Endocrinol Metab (1996) 0.81
Infections and autoimmune endocrine disease. Baillieres Clin Endocrinol Metab (1995) 0.81
The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse. Clin Dev Immunol (2004) 0.80
Relationship between HLA antigens and infectious agents in contributing towards the development of Graves' disease. Immunol Invest (1998) 0.79
Pharmacogenomics and its implications for autoimmune disease. J Autoimmun (2007) 0.79
Reverse transcriptase is elevated in the thyroid tissue from Graves' disease patients. Clin Endocrinol (Oxf) (2000) 0.79
Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus. J Viral Hepat (2000) 0.78
Presence of human T-lymphotropic virus type II-related genes in DNA of peripheral leukocytes from patients with autoimmune thyroid diseases. J Med Virol (1995) 0.78
Does infection initiate Graves disease? A population based 10 year study. Autoimmunity (1989) 0.78
Evidence for a retroviral trigger in Graves' disease. Autoimmunity (1995) 0.77